DHX9 and hepatocellular carcinoma: Subsequent analysis using the Kaplan–Meier Plotter demonstrated that HCC patients with high DHX9 expression experienced diminished overall survival and progression-free survival compared to those with low DHX9 expression (Figure 1F).